References
- Accuracy of the references is the responsibility of the authors.
- Chiang W, Goldfrank L. The medical complications of drug abuse. Med J Aust 1990: 152: 83–8
- Buchanan J, Brown C. “Designer drugs”: a problem in clinical toxicology. Med Toxicol1988: 3: 1–17
- Jekel JF, Allen DF. Trends in drug abuse in the mid-1980s. Yale J Biol Med 1987: 60: 45–52
- Vogtsberger KN. Designer drugs. Tex Med 1989: 85: 30–2
- Langston J, Ballard P, Tetrad J, et al. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983: 219: 979–80
- Schneider JS, Yuwiler A, Markham CH. Production of a Parkinson-like syndrome in the cat with n-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine (MPTP): behavior, histology, and biochemistry. Exp Neurol 1986: 91: 293–307
- Ford M, Hoffman RS, Goldfrank LR. Opioids and designer drugs. Emerg Med Clin North Am 1990: 8(3): 495–511
- Varon J, Jacobs MB. Treating the progressive stages of Parkinson's disease. Postgrad Med1991: 90(1): 63–71
- Chesher G. Designer drugs—the “whats” and the “whys.” Med J Aust 1990: 153: 157–61
- Ayres WA, Starsiak MJ, Sokolay P. The bogus drug: three methyl and alpha methyl fentanyl sold as “China white.” J Psychoactive Drugs 1981: 13(1): 91–3
- Ziporyn T. A growing industry and menace: makeshift laboratory's designer drugs. JAMA 1986: 256(22): 3061–3
- Climko RP, Roehrich H, Sweeney DR, et al. Ecstasy: a review of MDMA and MDA. Int J Psychiatry Med 1986–7;16(4): 359–72
- Dowling GP, McDonough ET, Bost RO.‘Eve’ and ‘ecstasy’: a report of five deaths associated with the use of MDEA and MDMA JAMA 1987: 257(12): 1615–7
- Beebe DK, Walley E. Substance abuse: the designer drugs. Am Fam Physician 1991: 43: 1689–98
- Barnes D. New data intensify the agony over ecstasy. Science 1988: 239: 864–6
- Nichols G, Davis G, Corrigan C, et al. Death associated with abuse of a “designer drug.” Kentucky Med Assoc J 1990: 88: 600–3
- Jackson B, Reed A. Another abusable amphetamine. (Letter) JAMA 1970: 211: 830
- Simpson DL, Rumack BH. Methylenedioxyamphetamine: clinical description of overdose, death, and review of pharmacology. Arch Intern Med 1981: 141: 1507–9
- Davis WM, Hatoum HT, Waters IW Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (ecstasy) abuse. Alcohol Drug Res 1987: 7: 123–34